– UK, London – The Biotech Growth Trust PLC (LON: BIOG) today announced the appointment of Hamish Baillie to its Board as an independent non-executive director effective from 1 November 2023.
“We are delighted to welcome Hamish Baillie to the Board. We are very pleased to have appointed a Director with such extensive experience and expertise both in managing an investment trust and as a non-executive director. Hamish’s skillset complements the experience and skills of the rest of the Board and we look forward to working together.” said Board chairman, Roger Yates.
Hamish Baillie will also join the Audit Committee, Management Engagement Committee, and Nominations Committee.
About Hamish Baillie
Hamish Baillie is a non-executive director of Mid Wynd International Investment Trust plc. His executive career was spent at Ruffer LLP, which he joined in 2002, becoming a partner in 2006. Between 2011 and 2022 he was the Lead Manager of Ruffer Investment Company Ltd. He founded and managed the Edinburgh office of Ruffer and held firm-wide responsibilities for portfolio management and investor communications. He was a member of the firm’s UK Wealth Leadership Team and a director of Ruffer (Channel Islands) Limited. He retired from Ruffer with effect from 3 October 2022.
SOURCE: https://www.biotechgt.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
